Application 019909

Type
NDA
Sponsor
MYLAN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ZOVIRAXACYCLOVIRSUSPENSION;ORAL200MG/5MLYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0378-8712AcyclovirAcyclovirMylan Pharmaceuticals Inc.NDA AUTHORIZED GENERICCurrent
0378-8712AcyclovirAcyclovirMylan Pharmaceuticals Inc.NDA AUTHORIZED GENERICCurrent
0378-9735ZoviraxAcyclovirMylan Pharmaceuticals Inc.NDACurrent
0378-9735ZoviraxAcyclovirMylan Pharmaceuticals Inc.NDACurrent
40076-953ZOVIRAXacyclovirPrestium Pharma, Inc.NDACurrent
40085-842AcyclovirAcyclovirRenaissance Pharma, Inc.NDA AUTHORIZED GENERICCurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84164SUPPL 2025-11-13
84152SUPPL 2025-11-13
19836SUPPL2008-08-13
34092SUPPL2005-12-15
19835SUPPL2005-12-15
19834SUPPL2004-05-27
11843SUPPL2004-05-27
34091SUPPL2003-06-10
11842SUPPL2003-06-10
41093SUPPL2000-07-06